South Shore Capital Advisors »

AstraZeneca shares owned by South Shore Capital Advisors

Quarter-by-quarter ownership of AstraZeneca shares owned by South Shore Capital Advisors from 13F filings

Historical chart of South Shore Capital Advisors investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by South Shore Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by South Shore Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $285k 3.1k 91.93

More positions owned by South Shore Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p Us Gwt (IUSG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Visa Com Cl A (V)
Spdr Gold Tr Gold Shs (GLD)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Johnson & Johnson (JNJ)
American Express Company (AXP)
Willis Towers Watson SHS (WTW)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)

View all positions for South Shore Capital Advisors

Top funds holding AstraZeneca

PRIMECAP Management Company
Wellington Management Company
FMR
Fisher Investments
Franklin Resources
Capital Research and Management Company - Division 3
Goldman Sachs Group
Sanders Capital
Ameriprise Financial
Atlantic Trust
Dimensional Fund Advisors
BlackRock
Arrowstreet Capital, Limited Partnership
Neuberger Berman Group
Northern Trust

View all funds holding AstraZeneca